Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed Mar 30, 2015 · 10-K · 89 days after period end · 0001193125-15-109883
derived · Computed from the longer spans the company filed.
no prior Q4 2013 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2014 · filed Mar 30, 2015 · 89 d after period end
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
